Surrozen (SRZN)

• Market cap: $210M
• 1 day: -1.49%
• 5 days: 6.67%
• 1 month: 18.55%
• 3 months: 101.98%
• 6 months: 143.34%
• Year to date: 13.6%
• 1 year: 128.79%
• 5 years: -84.68%
• 10 years: -83.86%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Employees: 41